Glutathionylation of proteins by glutathione disulfide S-oxide - PubMed (original) (raw)

Review

Glutathionylation of proteins by glutathione disulfide S-oxide

Kuo-Ping Huang et al. Biochem Pharmacol. 2002 Sep.

Abstract

Aqueous solution of S-nitrosoglutathione (GSNO) underwent spontaneous chemical transformation that generated several glutathione derivatives including glutathione sulfonic acid (GSO3H), glutathione disulfide S-oxide (GS(O)SG), glutathione disulfide S-dioxide, and glutathione disulfide. Surprisingly, GS(O)SG (also called glutathione thiosulfinate), which was not identified as a metabolite of GSNO previously, was one of the major products derived from GSNO. This compound was very reactive toward any thiol and the reaction product was a mixed disulfide. The rate of reaction of GS(O)SG with 5-mercapto-2-nitro-benzoate was nearly 20-fold faster than that of GSNO. The mechanism for the formation of GS(O)SG was believed to involve the sulfenic acid (GSOH) and thiosulfinamide (GS(O)NH2) intermediates; the former underwent self-condensation and the latter reacted with GSH to form GS(O)SG. Many reactive oxygen and nitrogen species were also capable of oxidizing GSH or GSSG to form GS(O)SG, which likely played a central role in integrating both the oxidative and nitrosative cellular responses through thionylation of thiols. Treatments of rat brain tissue slices with oxidants resulted in an enhanced thionylation of proteins with a concomitant increase in cellular level of GS(O)SG, suggesting that this compound might play a second messenger role for stimuli that produced a variety of oxidative species.

PubMed Disclaimer

Cited by

The glutathione system: a new drug target in neuroimmune disorders.
Morris G, Anderson G, Dean O, Berk M, Galecki P, Martin-Subero M, Maes M. Morris G, et al. Mol Neurobiol. 2014 Dec;50(3):1059-84. doi: 10.1007/s12035-014-8705-x. Epub 2014 Apr 22. Mol Neurobiol. 2014. PMID: 24752591 Review.
Glutathione: Pharmacological aspects and implications for clinical use in non-alcoholic fatty liver disease.
Santacroce G, Gentile A, Soriano S, Novelli A, Lenti MV, Di Sabatino A. Santacroce G, et al. Front Med (Lausanne). 2023 Mar 22;10:1124275. doi: 10.3389/fmed.2023.1124275. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37035339 Free PMC article. Review.
A novel role for human sulfiredoxin in the reversal of glutathionylation.
Findlay VJ, Townsend DM, Morris TE, Fraser JP, He L, Tew KD. Findlay VJ, et al. Cancer Res. 2006 Jul 1;66(13):6800-6. doi: 10.1158/0008-5472.CAN-06-0484. Cancer Res. 2006. PMID: 16818657 Free PMC article.
Regulation of the Proteolytic Activity of Cysteine Cathepsins by Oxidants.
Lalmanach G, Saidi A, Bigot P, Chazeirat T, Lecaille F, Wartenberg M. Lalmanach G, et al. Int J Mol Sci. 2020 Mar 12;21(6):1944. doi: 10.3390/ijms21061944. Int J Mol Sci. 2020. PMID: 32178437 Free PMC article. Review.
Cellular Compartmentalization, Glutathione Transport and Its Relevance in Some Pathologies.
Vázquez-Meza H, Vilchis-Landeros MM, Vázquez-Carrada M, Uribe-Ramírez D, Matuz-Mares D. Vázquez-Meza H, et al. Antioxidants (Basel). 2023 Mar 29;12(4):834. doi: 10.3390/antiox12040834. Antioxidants (Basel). 2023. PMID: 37107209 Free PMC article. Review.

Glutathionylation of proteins by glutathione disulfide S-oxide - PubMed (original) (raw)